Researchers have made progress with an AI-designed vaccine. A new model, which leverages generative AI to create novel protein structures, has shown promising results in preclinical trials. The AI algorithm identified protein targets that traditional methods might have missed, leading to a vaccine candidate with enhanced immunogenicity. While human trials are still pending, this advancement demonstrates AI’s potential to accelerate vaccine development and address future pandemics.
About the Author
